ceftriaxone sodium (60505-6151)

Drug Facts

Product Profile

Brand Name ceftriaxone sodium

Generic Name ceftriaxone sodium

Labeler apotex corp.

Dosage Form INJECTION, POWDER, FOR SOLUTION

Routes

INTRAMUSCULAR INTRAVENOUS

Active Ingredients

ceftriaxone sodium 250 mg/1

Manufacturer

Apotex Corp.

Identifiers & Regulatory

Product NDC 60505-6151

Product ID 60505-6151_0432e6c3-ad77-726c-e063-6294a90a798c

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA203702

Listing Expiration 2026-12-31

Marketing Start 2017-06-30

Pharmacologic Class

Classes

cephalosporin antibacterial [epc] cephalosporins [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 605056151

Hyphenated Format 60505-6151

Supplemental Identifiers

RxCUI

309092 1665005 1665021 1665046

UPC

0360505615216 0360505615247 0360505615148 0360505614806 0360505614844 0360505614905

UNII

023Z5BR09K

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ceftriaxone sodium (source: ndc)

Generic Name ceftriaxone sodium (source: ndc)

Application Number ANDA203702 (source: ndc)

Routes

INTRAMUSCULAR INTRAVENOUS

source: ndc

Resolved Composition

Strengths

250 mg/1

source: ndc

Packaging

10 VIAL, SINGLE-USE in 1 CARTON (60505-6151-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE
1 VIAL, SINGLE-USE in 1 CARTON (60505-6151-4) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE

source: ndc

Packages (2)

60505-6151-1 10 VIAL, SINGLE-USE in 1 CARTON (60505-6151-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE 60505-6151-4 1 VIAL, SINGLE-USE in 1 CARTON (60505-6151-4) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE

Ingredients (1)

ceftriaxone sodium (250 mg/1)

Linked Drug Pages (1)

Ceftriaxone Sodium ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "0432e6c3-ad77-726c-e063-6294a90a798c", "openfda": {"upc": ["0360505615216", "0360505615247", "0360505615148", "0360505614806", "0360505614844", "0360505614905"], "unii": ["023Z5BR09K"], "rxcui": ["309092", "1665005", "1665021", "1665046"], "spl_set_id": ["5116231f-82d1-44be-b08e-560c9a50e5c5"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-USE in 1 CARTON (60505-6151-1)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE", "package_ndc": "60505-6151-1", "marketing_start_date": "20170630"}, {"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (60505-6151-4)  / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE", "package_ndc": "60505-6151-4", "marketing_start_date": "20170630"}], "brand_name": "Ceftriaxone Sodium", "product_id": "60505-6151_0432e6c3-ad77-726c-e063-6294a90a798c", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Cephalosporin Antibacterial [EPC]", "Cephalosporins [CS]"], "product_ndc": "60505-6151", "generic_name": "Ceftriaxone Sodium", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ceftriaxone Sodium", "active_ingredients": [{"name": "CEFTRIAXONE SODIUM", "strength": "250 mg/1"}], "application_number": "ANDA203702", "marketing_category": "ANDA", "marketing_start_date": "20170630", "listing_expiration_date": "20261231"}